PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

As Republicans gear up to pass the first major tax bill since the 2017 Tax Cuts and Jobs Act, Citibank hired Ernst & Young ...

Several top lobbying names on Washington, D.C.'s K Street, who have voiced opposition to President Donald Trump in the past, ...

Investigators reported that the amount of nano and microplastics detected in brain samples is increasing but urge caution in ...